Ankylose This! Living with Ankylosing Spondylitis

Wednesday, June 07, 2006

Humira approved for AS in Europe

European regulators have now given Abbott Labs permission to market Humira (adalimumab) as a treatment for ankylosing spondylitis: Business Week; The FDA is still reviewing the application in the U.S.

See previous entries: Adalimumab (Humira) and ankylosing spondylitis; More about adalimumab; Humira recommended for AS in Europe.

Update, June 8: Chicago Tribune.

Comments on this post

Post a Comment

Links to this post

Create a Link